Can the response to Omalizumab be influenced by treatment duration? A real-life study
Conclusion In real-life, the positive Omalizumab response remained stable for over 60 months. Long term Omalizumab treatment may lead to a discontinuation of some associated medications and to a slowing down of FEV1 decline.
Source: Pulmonary Pharmacology and Therapeutics - Category: Respiratory Medicine Source Type: research
More News: Asthma | Corticosteroid Therapy | Drugs & Pharmacology | Respiratory Medicine | Study | Xolair